CONCERT PHARMACEUTICALS, INC. | Business Contracts

Contingent Value Rights Agreement, dated as of March 6, 2023, by and among Sun Pharmaceutical Holdings USA, Inc., Sun Pharmaceutical Industries Ltd., Computershare Inc. and... (Filed With SEC on March 6, 2023)

Agreement and Plan of Merger, dated as of January 19, 2023, by and among Sun Pharmaceutical Industries Ltd., Foliage Merger Sub, Inc. and Concert Pharmaceuticals, Inc (Filed With SEC on January 19, 2023)

Summary of Non-Employee Director Compensation Program (Filed With SEC on March 3, 2022)

Open Market Sale Agreement dated March 1, 2019 by and between Concert Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on March 1, 2019)

Form of Warrant Amendment Agreement (Filed With SEC on June 3, 2022)

Underwriting Agreement, dated June 1, 2022, by and between the Company and Jefferies LLC and Truist Securities, Inc., as representatives of the several underwriters named therein (Filed With SEC on June 3, 2022)

Royalty Purchase Agreement, dated as of November 3, 2021, by and among the Registrant and the Buyers (Filed With SEC on March 3, 2022)

Description of Capital Stock (Filed With SEC on March 3, 2022)

Form of Warrant (Filed With SEC on November 8, 2021)

Securities Purchase Agreement, dated November 3, 2021 (Filed With SEC on November 8, 2021)

Amendment to Asset Purchase Agreement, dated as of May 17, 2021, by and among the Registrant, Vertex Pharmaceuticals (Europe) Limited, as Buyer, and Vertex Pharmaceuticals... (Filed With SEC on May 17, 2021)

Summary of Non-Employee Director Compensation Program (Filed With SEC on February 25, 2021)

Summary of Non-Employee Director Compensation Program (Filed With SEC on February 27, 2020)

Form of Employment Agreement by and between the Registrant and each non-CEO executive officer (Filed With SEC on February 27, 2020)

Employment Agreement, dated as of October 31, 2018, by and between the Registrant and Roger D. Tung (Filed With SEC on February 27, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

Form of Pre-Funded Warrant (Filed With SEC on January 28, 2020)

Underwriting Agreement, dated as of January 28, 2020, by and between the Company and Jefferies LLC, as representative of the several underwriters named therein (Filed With SEC on January 28, 2020)

Summary of Director Compensation Program (Filed With SEC on February 28, 2019)

CONCERT PHARMACEUTICALS, INC. (19)